Revenue Breakdown
Composition ()
No data
Revenue Streams
Precigen Inc (PGEN) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Product, accounting for 93.9% of total sales, equivalent to $21.83M. Another important revenue stream is Service. Understanding this composition is critical for investors evaluating how PGEN navigates market cycles within the Pharmaceuticals industry.
Profitability & Margins
Evaluating the bottom line, Precigen Inc maintains a gross margin of 88.99%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -25.78%, while the net margin is -34.10%. These profitability ratios, combined with a Return on Equity (ROE) of -12418.40%, provide a clear picture of how effectively PGEN converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, PGEN competes directly with industry leaders such as QURE and NVAX. With a market capitalization of $1.55B, it holds a significant position in the sector. When comparing efficiency, PGEN's gross margin of 88.99% stands against QURE's 93.85% and NVAX's 78.00%. Such benchmarking helps identify whether Precigen Inc is trading at a premium or discount relative to its financial performance.
